References
- Harneshaug M, Benth JS, Kirkhus L, Gronberg BH, Bergh S, Rostoft S, Slaaen M. CT derived muscle measures, inflammation, and frailty in a cohort of older cancer patients. In Vivo. 2020;34(6):3565–72. doi:https://doi.org/10.21873/invivo.12200
- Dunne RF, Loh KP, Williams GR, Jatoi A, Mustian KM, Mohile SG. Cachexia and sarcopenia in older adults with cancer: a comprehensive review. Cancers (Basel). 2019;11(12):1861. doi:https://doi.org/10.3390/cancers11121861
- Lee JS, Kim YS, Kim EY, Jin W. Prognostic significance of CT-determined sarcopenia in patients with advanced gastric cancer. PLoS One. 2018;13(8):e0202700. doi:https://doi.org/10.1371/journal.pone.0202700
- Fukushima H, Yokoyama M, Nakanishi Y, Tobisu K, Koga F. Sarcopenia as a prognostic biomarker of advanced urothelial carcinoma. PLoS One. 2015;10(1):e0115895. doi:https://doi.org/10.1371/journal.pone.0115895
- Harimoto N, Shirabe K, Yamashita Y-I, Ikegami T, Yoshizumi T, Soejima Y, Ikeda T, Maehara Y, Nishie A, Yamanaka T, et al. Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma. Br J Surg. 2013;100(11):1523–30. doi:https://doi.org/10.1002/bjs.9258
- Kim EY, Kim YS, Park I, Ahn HK, Cho EK, Jeong YM. Prognostic significance of CT-determined sarcopenia in patients with small-cell lung cancer. J Thorac Oncol. 2015;10(12):1795–9. doi:https://doi.org/10.1097/JTO.0000000000000690
- Peng P, Hyder O, Firoozmand A, Kneuertz P, Schulick RD, Huang D, Makary M, Hirose K, Edil B, Choti MA, et al. Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma. J Gastrointest Surg. 2012;16(8):1478–86. doi:https://doi.org/10.1007/s11605-012-1923-5
- Jo S, Sebro R. CT attenuation and cross-sectional-area index of the pectoralis are associated with prognosis in sarcoma patients. Anticancer Res. 2021;41(4):1927–35. doi:https://doi.org/10.21873/anticanres.14959
- Phan EN, Thorpe SW, Wong FS, Saiz AM, Taylor SL, Canter RJ, Lenchik L, Randall RL, Boutin RD. Opportunistic muscle measurements on staging chest CT for extremity and truncal soft tissue sarcoma are associated with survival. J Surg Oncol. 2020;122(5):869–76. doi:https://doi.org/10.1002/jso.26077
- Wilson RJ, Alamanda VK, Hartley KG, Mesko NW, Halpern JL, Schwartz HS, Holt GE. Sarcopenia does not affect survival or outcomes in soft-tissue sarcoma. Sarcoma. 2015;2015:146481. doi:https://doi.org/10.1155/2015/146481
- Hendrickson NR, Mayo Z, Shamrock A, Kesler K, Glass N, Nau P, Miller BJ. Sarcopenia is associated with increased mortality but not complications following resection and reconstruction of sarcoma of the extremities. J Surg Oncol. 2020;121(8):1241–8. doi:https://doi.org/10.1002/jso.25898
- Boutin RD, Katz JR, Chaudhari AJ, Yabes JG, Hirschbein JS, Nakache Y-P, Seibert JA, Lamba R, Fananapazir G, Canter RJ, et al. Association of adipose tissue and skeletal muscle metrics with overall survival and postoperative complications in soft tissue sarcoma patients: an opportunistic study using computed tomography. Quant Imaging Med Surg. 2020;10(8):1580–9. doi:https://doi.org/10.21037/qims.2020.02.09
- Hirai T, Kobayashi H, Okuma T, Ishibashi Y, Ikegami M, Ohki T, Shinoda Y, Okajima K, Zhang L, Akiyama T, et al. Skeletal muscle measurements predict surgical wound complications but not overall survival in patients with soft tissue sarcoma. Jpn J Clin Oncol. 2020;50(10):1168–74. doi:https://doi.org/10.1093/jjco/hyaa100
- Veld J, Vossen JA, De Amorim Bernstein K, Halpern EF, Torriani M, Bredella MA. Adipose tissue and muscle attenuation as novel biomarkers predicting mortality in patients with extremity sarcomas. Eur Radiol. 2016;26(12):4649–55. doi:https://doi.org/10.1007/s00330-016-4306-6
- Kinsey CM, San José Estépar R, van der Velden J, Cole BF, Christiani DC, Washko GR. Lower pectoralis muscle area is associated with a worse overall survival in non-small cell lung cancer. Cancer Epidemiol Biomarkers Prev. 2017;26(1):38–43. doi:https://doi.org/10.1158/1055-9965.EPI-15-1067
- Miller JA, Harris K, Roche C, Dhillon S, Battoo A, Demmy T, Nwogu CE, Dexter EU, Hennon M, Picone A, et al. Sarcopenia is a predictor of outcomes after lobectomy. J Thorac Dis. 2018;10(1):432–40. doi:https://doi.org/10.21037/jtd.2017.12.39
- Sun C, Anraku M, Kawahara T, Karasaki T, Kitano K, Nagayama K, Sato M, Nakajima J. Prognostic significance of low pectoralis muscle mass on preoperative chest computed tomography in localized non-small cell lung cancer after curative-intent surgery. Lung Cancer. 2020;147:71–6. doi:https://doi.org/10.1016/j.lungcan.2020.07.008
- Derstine BA, Holcombe SA, Ross BE, Wang NC, Su GL, Wang SC. Skeletal muscle cutoff values for sarcopenia diagnosis using T10 to L5 measurements in a healthy US population. Sci Rep. 2018;8(1):11369. doi:https://doi.org/10.1038/s41598-018-29825-5
- Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, Fearon K, Hütterer E, Isenring E, Kaasa S, et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr. 2017;36(1):11–48. doi:https://doi.org/10.1016/j.clnu.2016.07.015
- Woo J, Arai H, Ng TP, Sayer AA, Wong M, Syddall H, Yamada M, Zeng P, Wu S, Zhang TM. Ethnic and geographic variations in muscle mass, muscle strength and physical performance measures. Eur Geriatr Med. 2014;5(3):155–64. doi:https://doi.org/10.1016/j.eurger.2014.04.003